byetta glp-1 pharmaceutical company overview GLP-1s & Beyond: Understanding Incretin Mimetic Opportunities The future of GLP-1 drugs

These may include: other FDA-approved weight-loss medications structured medical weight-management programs nutrition and behavioral counseling supervised exercise interventions long-term clinical monitoring Some older medications are available in generic form and may be less expensive, although experts note they may not produce the same degree of weight loss as GLP-1 therapies

But then, his doctor made a recommendation

Significant weight loss also was observed in a cohort study in the clinical setting where overweight patients lost an average of 10.9% of starting body weight by 6 months (Ghusn et al., 2022)

Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite Type 1 Diabetes TrialNet data

Lancet Regional Health Southeast Asia , 14, 100210

It depends on the area and how loose the skin is